Synthesis and antitubercular screening of imidazole derivatives

European Journal of Medicinal Chemistry

Volumn 44, Issue 8, 2009, Pages 3350-3355

  Pandey, Jyoti ^a   Tiwari, Vinod K ^a   Verma, Shyam S ^a   Chaturvedi, Vinita ^a   Bhatnagar, S ^a   Sinha, S ^a   Gaikwad, A N ^a   Tripathi, Rama P ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

C alkylation; C Allyl imidazoles; Glycosyl amino ester; Imidazoles; Tuberculosis

Indexed keywords

1,3 BIS(2 PROPYLIMIDAZOL 1 YL)PROPANE; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

AGAR DILUTION; ALKYLATION; AMIDATION; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; IMIDAZOLES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

EID: 67349203201     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.02.013     Document Type: Article

References (35)

1. Stokstad E. Science 287 (2000) 2391
2. WHO Global Tuberculosis Programme - Tuberculosis Fact Sheet, Global Tuberculosis Control, WHO Report 2001, World Health Organization, 2002.
3. World Health Organization, Geneva, Switzerland, WHO/CDS/TB/2001, 287. http://www.who.int/mediacentre/factsheets/who104/en/index.html.
4. Mooran N. Nat. Med. 2 (1996) 377
5. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. J. Am. Med. As. 282 (1999) 677
6. Dooley S.W., Jarvis W.R., Martone W.J., and Snyder D.E. Ann. Intern. Med. 117 (1992) 257
7. Raviglione M.C., Snider D.E., and Kochi A. Am. Med. As. 273 (1995) 220
8. Farmer P., Bayona J., Beccera M., Henry J., Furin C., Hiarr H., Kim J.Y., Mimic C., Nardell E., and Shin S. Int. J. Tuberc. Lung. Dis. 2 (1998) 869-876
9. A. Hudson, T. Imamura, W. Gutteridge, T. Kanyok, P. Nunn, W.H.O. TDR/PRD/03.1W, Geneva, 2003.
10. Tripathi R.P., Tewari N., Dwivedi N., and Tiwari V.K. Med. Res. Rev. 25 (2005) 93-131
11. Banfi E., Scialino G., Zampieri D., Mamolo M.G., Vio L., Ferrone M., Fermeglia M., Paneni M.S., and Pricl S. J. Antimicrob. Chemother. 58 (2006) 76-84
12. Banfi E., Mamolo M.G., Vio L., and Predominato M. J. Chemother. 5 (1993) 164-167
13. Banfi E., Mamolo M.G., Zampieri D., Vio L., and Bragadin C.M. J. Antimicrob. Chemother. 48 (2001) 705-707
14. Jackson C.J., Lamb D.C., Kelly D.E., and Kelly S.L. FEMS Microbiol. Lett. 192 (2000) 159-162
15. Guardiola-Diaz H.M., Foster L.A., Mushrush D., and Alfin D.N.V. Biochem. Pharmacol. 61 (2001) 1463-1470
16. Zhang W.J., Ramamoorthy Y., Kilicarslan T., Nolte H., Tyndale R.F., and Sellers E.M. Drug Metab. Dispos. 30 (2002) 314-318
17. Podust L.M., Poulos T.L., and Waterman M.R. Proc. Natl. Am. Soc. U.S.A. 98 (2001) 3068-3073
18. Bellamine A., Mangla A.T., David W.N., and Waterman M.R. Biochemistry 96 (1999) 8937-8942
19. Stover C.K., Warrener P., VanDevante D.R., Sherman D.R., Arain T.M., Langhorne M.H., Anderson S.W., Towell J.A., Yuan Y., McMurray D.N., Kreiswirth B.N., Barry C.E., and Baker W.R. Nature 405 (2000) 962-966
20. Tripathi R.P., Tripathi R., Tiwari V.K., Bala L., Sinha S., Srivastava A., Srivastava R., and Srivastava B.S. Eur. J. Med. Chem. 37 (2002) 773-781
21. Tewari N., Tiwari V.K., Mishra R.C., Tripathi R.P., Srivastava A.K., Ahmad R., Srivastava R., and Srivastava B.S. Bio-Org. Med. Chem. 11 (2003) 2911-2922
22. Tewari N., Tiwari V.K., Tripathi R.P., Gaikwad A., Sinha S., Chaturvedi A.K., Shukla P.K., Srivastava R., and Srivastava B.S. Bio-Org. Med. Chem. Lett. 14 (2003) 329-332
23. Katiyar D., Tiwari V.K., Tiwari N., Verma S.S., Sinha S., Giakwad A., Srivastava A., Chaturvedi V., Srivastava R., Srivastava B.S., and Tripathi R.P. Eur. J. Med. Chem. 40 (2005) 351-360
24. Tripathi R.P., Tiwari V.K., Tiwari N., Giakwad A., Sinha S., Srivastava S., Chaturvedi V., and Srivastava B.S. Bio-Org. Med. Chem. 13 (2005) 5668-5679
25. Tiwari V.K., and Tripathi R.P. Ind. J. Chem. 41B (2002) 1681-1685
26. Collins L.A., and Franzblau S.G. Antimicrob. Agents Chemother. 41 (1997) 1004-1009
27. Franzblau S.G., Witzig R.S., Mclaughlin J.C., Torres P., Madico G., Hernandez A., Degnan M.T., Cook M.B., Quenzer V.K., Ferguson R.M., and Gillman R.H. J. Clin. Microbiol. 36 (1998) 362-366
28. Saita H., Tomioka H., Sato K., Yamne T., Yamashita K., and Hosol K. Antimicrob. Agents Chemother. 35 (1991) 542-547
29. Lee C.N., and Heifets L.B. Am. Rev. Respir. Dis. 136 (1987) 349-352
30. Siddiqui S.H. In: Isenberg H.D. (Ed). Radiometric (BACTEC) Test for Slowly Growing Mycobacteria, in Clinical Microbiology Procedures Handbook vol. 1 (1992), American Society for Microbiology, Washington D.C. 5.14.2-5.14.25
31. Inderlied C.B., and Salfinger M. Existing methods for drug susceptibility testing of clinical M. tuberculosis isolates are either inexpensive with long turnaround. In: Murray P.R., Barron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Antimicrobial Agents and Susceptibility Tests: Mycobacteria. sixth ed. Manual of Clinical Microbiology (1995), ASM Press, Washington, D.C 1385-1404
32. Zaderenko P., Gil M.S., and Ballesteros P. J. Org. Chem. 59 (1994) 6268-6273
33. Tomapatanaget B., Tuntulani T., Wisner J.A., and Beer P.D. Tetrahedron Lett. 45 (2004) 663-666
34. Easson A.P.T., and Pyman F.L. A General Method for the Preparation of 1-Substituted Glyoxalines from Acetalylthiocarbirnide and Primary Amines (1932), Hodg-son and Crook Research Laboratories, Messrs. Boots Pure Drug Co., Ltd., Nottingham
35. Wong W.W.H., Vickers M.S., Cowley A.R., Paul R.L., and Beer P.D. Org. Bio. Chem. 3 (2005) 4201